tldrdailynews.com logo

Moderna Roivant patent deal caps biotech patent fight at $2.25B

1 min read
Source: statnews.com
Moderna Roivant patent deal caps biotech patent fight at $2.25B
Photo: statnews.com
TL;DR

Moderna will pay Roivant up to $2.25 billion to settle patent infringement claims over its Covid-19 vaccine, while The Readout highlights Prime Medicine’s gene-therapy work and FDA warnings to telehealth firms over compounded GLP-1s.

Topics:businessbiotechnology#biotechnology#gene-therapy#moderna#patent-settlement#prime-medicine#roivant
Share this article
  1. FDA warns more telehealth firms about compounded GLP-1s  statnews.com
  2. FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s  The Hill
  3. US FDA warns 30 telehealth firms over misleading ads for compounded weight‑loss drugs  Reuters
  4. FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters  Fierce Pharma
  5. Independent pharmacy labs, users, push back against FDA’s GLP-1 drug warning  Capital Gazette

Want the full story? Read the original reporting

Read on statnews.com